Carlos Cordon‐Cardo

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

15

H-Index

1

About

Dr. Carlos Cordon‐Cardo is a leading urologic pathologist whose research centers on prostate cancer biology, tumor microenvironment, and the molecular determinants of disease aggressiveness. His work has fundamentally advanced the understanding of how inflammatory processes within the pelvic region influence prostate cancer progression. In a landmark 2022 study, Dr. Cordon‐Cardo and his team were the first to demonstrate a significant association between incidental pelvic inflammation and aggressive prostate cancer, revealing that localized inflammatory responses can directly impact tumor biology and clinical outcomes following radical prostatectomy. This seminal paper has already garnered 15 citations, underscoring its immediate impact on the field. Beyond this key contribution, Dr. Cordon‐Cardo has made extensive contributions to prostate cancer grading, biomarker discovery, and the characterization of premalignant lesions. His research bridges histopathology with clinical practice, providing critical insights that help refine risk stratification and guide therapeutic decisions for patients with prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer
15 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago